close :

:

Forgotten your password?
 

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including pharmaceutical industry news, new drug approvals, applications and clinical trial results.

Pharma News

MARTINSRIED/MUNICH, Germany, July 8, 2008- MediGene AG (Frankfurt, Prime Standard: MDG) has put an ongoing phase I study involving the drug candidate RhuDex® on hold. According to information obtained by MediGene, one of the...
DUBLIN, Ohio, July 08, 2008 /PRNewswire-FirstCall/ -- Cardinal Health, a global provider of products and services that improve the safety and productivity of health care, today announced a consolidation of its businesses into two primary operating...
SYDNEY, Australia, 8 July, 2008 - Giaconda Limited (ASX: GIA), today announced that it has suspended its Phase IIa trial of Hepaconda for the treatment of Hepatitis C in people with "genotype 1" infection that does not respond to current therapy....
HUENENBERG, Switzerland--(BUSINESS WIRE)--Jul 8, 2008 - Novartis AG and Nestle S.A. announced today that they have completed the first step purchase and sale of 74 million shares of Alcon, Inc. (NYSE: ACL) common stock currently owned by Nestle...

More...

New Drug Approvals

CARLSBAD, Calif.--(BUSINESS WIRE)--Jul 8, 2008 - Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, today announced it has received U.S. Food and Drug Administration...
First Organ-specific MRI Contrast Agent Approved in the United States in More Than a Decade WAYNE, N.J., July 08, 2008 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc., a leader in diagnostic imaging, announced today that the U.S. Food and...
LIBERTY CORNER, N.J., July 03, 2008 /PRNewswire/ -- On June 27, 2008 GeneraMedix Inc. received approval from the U.S. Food and Drug Administration (FDA) for its Epoprostenol for Injection 1.5 mg New Drug Application (NDA). Epoprostenol for...
Xience V, Only Drug Eluting Stent to Demonstrate Superiority Over Market-Leading Stent in Clinical Trials, Now Available in United States for Treatment of Coronary Artery Disease ABBOTT PARK, Ill., July 02, 2008 /PRNewswire-FirstCall/ -- Abbott...
ROCKVILLE, Md., July 1, 2008-The U.S. Food and Drug Administration today approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder,...

More...

New Drug Applications

BETHLEHEM, Pa., July 07, 2008 /PRNewswire/ -- Digestive Care, Inc. (DCI) announced today that it has submitted the first module of its New Drug Application ("NDA") for Pancrecarb (pancrelipase), used in the treatment of Exocrine...
BASKING RIDGE, N.J., July 1, 2008 - VioQuest Pharmaceuticals (OTCBB: VOQP) today announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA). The application seeks marketing clearance for Xyfid...
MELBOURNE, Australia & MENLO PARK, Calif.-- ChemGenex Pharmaceuticals announced today that it has submitted the non-clinical section of the rolling submission of a New Drug Application (NDA) for omacetaxine mepesuccinate (formerly known as...
BRIDGEWATER, NJ--(Marketwire - June 30, 2008) - Alpharma Inc., a global specialty pharmaceutical company, today announced that it has resubmitted its New Drug Application ("NDA") for Embeda (morphine sulfate extended-release with sequestered...
LEXINGTON, Mass.--(BUSINESS WIRE)--Jul 1, 2008 - EPIX Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery...

More...

Clinical Trials

AUSTIN, Texas--(BUSINESS WIRE)--Jul 8, 2008 - Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will host a conference call with management and invited clinical experts on Thursday, July 10, 2008 at 3:30 p.m. ET. Introgen management...
Corifollitropin alfa meets primary endpoints in ENGAGE Trial KENILWORTH, N.J., July 08, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corp., announced today that corifollitropin alfa, its experimental, sustained follicle stimulant (SFS) met...
WellPoint's Health Outcomes Subsidiary HealthCore Finds Optimal Outcomes Can Be Achieved Through Compliant Use of Orally Administered Controllers INDIANAPOLIS, July 08, 2008 /PRNewswire/ -- Compliance with inhaled medications for asthma can improve...
GLP-1 Has Potential to Treat Type 2 Diabetes Using Emisphere's Eligen(R) Technology CEDAR KNOLLS, N.J., July 8, 2008 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. today announced findings from a clinical study assessing the oral delivery of...

More...

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 8, 2008
Audience: Healthcare professionals, consumers[Posted 07/08/2008] FDA notified healthcare professionals that a BOXED WARNING and...
July 2, 2008
Audience: Consumers, healthcare professionals [Posted 07/02/2008] Jack Distribution, LLC issued a voluntary nationwide recall of...
July 2, 2008
Audience: Orthopedic surgeons, neurosurgeons, hospital risk managers, surgical service staff [Posted 07/02/2008] FDA informed...
July 1, 2008
Audience: Transplantation specialists, infectious disease specialists, other healthcare professionals[UPDATE 07/01/2008] Novartis...
More...
Latest Drug Information Updates

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

Rotarix
Rotarix is an oral, two-dose, live attenuated vaccine for the prevention of rotavirus gastroenteritis in children.

More...